A Safety and Efficacy Study of Pracinostat and Azacitidine in Patients With High Risk Myelodysplastic Syndromes
Clinical trial NCT03151304 · TERMINATED
Trial details
- NCT number
- NCT03151304
- Sponsor
- Helsinn Healthcare SA
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-01
- Primary completion
- 2020-12-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.